Brightsurf Science News and Current Science News Events
 

Naltrexone News | Naltrexone Current Events
Page 1 of 1 | 19 Results
Previous01   Next   
Sort By: Page Views | Date
Elsevier
Naltrexone is one of four oral medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of alcoholism.   view more (2007-09-20)

Naltrexone is effective for Alaska Natives and other Alaskans living in rural areas
Access to treatment for alcohol dependence (AD) in rural and remote areas is limited.   view more (2008-05-12)

Pilot study shows withdrawal drug offers symptom relief to Crohn's sufferers
A Penn State College of Medicine pilot study suggests a low dose of naltrexone, a drug used to ease symptoms of alcohol and drug addiction, may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans.   view more (2007-02-05)

DNA highly-promising predictor for successful treatment of alcoholics
According to Dutch researcher Wendy Ooteman, the biological and genetic characteristics of alcoholics can predict which drugs will best suppress the desire to drink.    view more (2006-10-05)

Particular treatments effective for alcohol dependence
Medical management combined with the drug naltrexone or with a specialized behavioral therapy can be effective treatments for alcohol dependence.   view more (2006-05-03)

Study does not support use of anesthesia as heroin withdrawal method
The use of general anesthesia for heroin detoxification offers no benefit when compared to two other methods, and is associated with several potentially life-threatening adverse events.   view more (2005-08-24)

Drug may help women stop smoking
Adding the opiate blocker naltrexone to the combination of behavioral therapy and nicotine patches boosted smoking cessation rates for women by almost 50 percent when assessed after eight weeks of treatment.   view more (2006-10-09)

Drug commonly used for alcoholism curbs urges of pathological gamblers
A drug commonly used to treat alcohol addiction has a similar effect on pathological gamblers - it curbs the urge to gamble and participate in gambling-related behavior, according to a new research at the University of Minnesota.   view more (2008-06-16)

Gene variant predicts medication response in patients with alcohol dependence
Patients with a certain gene variant drank less and experienced better overall clinical outcomes than patients without the variant while taking the medication naltrexone, according to an analysis of participants in the National Institutes of Health's 2001-2004 COMBINE (Combined Pharmacotherapies... view more (2008-02-11)

Effective alcohol dependence treatments defined
The medication naltrexone and up to 20 sessions of alcohol counseling by a behavioral specialist are equally effective treatments for alcohol dependence when delivered with structured medical management.   view more (2006-05-03)

Penn State research shows withdrawal drug offers relief for Crohn's sufferers
A Penn State College of Medicine pilot study suggests that a drug used to ease symptoms of alcohol and drug addiction may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans.   view more (2006-05-30)

Microneedles enhance drug administration through skin
In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated that patches coated on one side with microscopic needles can facilitate transdermal... view more (2008-02-05)

Medication appears effective in treating teen heroin addiction
In a comparison of two drugs prescribed to treat teenagers dependent on heroin and other opioids, the drug buprenorphine was more effective, especially in treatment retention.   view more (2005-10-04)

Under certain genetic circumstances, naltrexone may increase the urge to drink
Naltrexone (NTX) is able to reduce drinking and craving among many alcoholics and heavy drinkers, but not all of them. Polymorphisms in the D4 dopamine receptor (DRD4) gene and the ì opiate receptor (OPRM1) gene may moderate NTX's effects on craving.   view more (2006-07-25)

Alcohol-deterrent drugs help patients achieve high rates of long-term abstinence
Studies investigating the long-term outcomes of alcoholism treatment are rare and inconsistent.   view more (2006-01-04)

The G allele of the mu-opioid receptor gene is linked to craving for alcohol
The study of genes and their influence on alcohol consumption can operate on many different levels. Some studies examine how genes may interact with the environment, some look specifically at family history of alcohol dependence, and some zero in on "pieces" of genes and their influence... view more (2007-01-04)

Data demonstrates alcohol does not significantly affect pharmacokinetics of Kadian
Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, presented results of a Phase IV study of KADIAN® (morphine sulfate extended-release) Capsules that demonstrate the pharmacokinetics of the long-acting opioid are not significantly affected by the consumption of... view more (2007-02-12)

Small study points to addictive effects of frequent tanning
Frequent users of tanning beds may be getting more out of the experience than darker skin, according to researchers from Wake Forest University Baptist Medical Center.   view more (2006-03-29)

Alcoholism-treatment medication acamprosate may help abstinent alcoholics sleep better
Alcoholics generally don't sleep well. Nor does abstinence improve the situation much. In fact, sleep difficulties during alcohol abstinence may be responsible for a relapse to alcoholism as individuals attempt to self medicate their sleeping problems.   view more (2006-08-28)
Page 1 of 1 | 19 Results
Previous01   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com